People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Everist Genomics, Inc. | — | Biotechnology | Series A | $12.5M | $110.7M | 2012 |
| Angiologix Inc. | — | Other Health Care | Seed | $1.8M | $44.6M | 2010 |
Thomas Stephen Everist at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Stephen Everist on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Prasad Sunkara | 2 | 2 |
| William P Worzel | 1 | 2 |
| Thomas Everist | 1 | 1 |
| Randal Charlton | 1 | 1 |
| Alex Charlton | 1 | 1 |
| Steve Everist | 1 | 1 |
| Tom Everist | 1 | 1 |
| Maria Merchant | 1 | 1 |
| Alexandr Parfenov | 1 | 1 |
| Mark Schlossberg | 1 | 1 |
| Alex P Charlton | 1 | 1 |
| Bill Worzel | 1 | 1 |
| Randal P Charlton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.